StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.90−0.18 (-8.65%)

Close on Nov 16, 2026Market cap $1.56MP/E –Yield –

Genprex cash

Cash and short-term investments held at the end of each period.

Genprex's cash was $15.15M at Jun 30, 2026. For fiscal 2025 it was $7.83M, up 388.9% from the year before. Over ten years it grew 42.0% a year on average. The highest annual figure on record is $38.63M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.83M+388.9%
FY2024Dec 31, 2024$1.60M-76.2%
FY2023Dec 31, 2023$6.74M-67.8%
FY2022Dec 31, 2022$20.95M-45.8%
FY2021Dec 31, 2021$38.63M+41.4%
FY2020Dec 31, 2020$27.32M+1264.3%
FY2019Dec 31, 2019$2.00M-76.7%
FY2018Dec 31, 2018$8.60M+5233.9%
FY2017Dec 31, 2017$161.25K-89.9%
FY2016Dec 31, 2016$1.60M+584.1%
FY2015Dec 31, 2015$234.22K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.15M+1025.2%
Q1 FY2026Mar 31, 2026$18.05M+420.4%
Q4 FY2025Dec 31, 2025$7.83M+388.9%
Q3 FY2025Sep 30, 2025$1.10M-25.9%
Q2 FY2025Jun 30, 2025$1.35M-45.2%
Q1 FY2025Mar 31, 2025$3.47M-57.8%
Q4 FY2024Dec 31, 2024$1.60M-76.2%
Q3 FY2024Sep 30, 2024$1.49M-87.3%
Q2 FY2024Jun 30, 2024$2.46M-75.3%
Q1 FY2024Mar 31, 2024$8.22M-54.6%
Q4 FY2023Dec 31, 2023$6.74M-67.8%
Q3 FY2023Sep 30, 2023$11.71M-54.1%
Q2 FY2023Jun 30, 2023$9.96M-66.9%
Q1 FY2023Mar 31, 2023$18.08M-47.7%
Q4 FY2022Dec 31, 2022$20.95M-45.8%
Q3 FY2022Sep 30, 2022$25.52M-39.3%
Q2 FY2022Jun 30, 2022$30.05M-32.1%
Q1 FY2022Mar 31, 2022$34.56M-26.6%
Q4 FY2021Dec 31, 2021$38.63M+41.4%
Q3 FY2021Sep 30, 2021$42.02M+99.5%
Q2 FY2021Jun 30, 2021$44.24M+100.0%
Q1 FY2021Mar 31, 2021$47.07M+103.9%
Q4 FY2020Dec 31, 2020$27.32M+1264.3%
Q3 FY2020Sep 30, 2020$21.06M+726.3%
Q2 FY2020Jun 30, 2020$22.13M+392.1%
Q1 FY2020Mar 31, 2020$23.08M+232.3%
Q4 FY2019Dec 31, 2019$2.00M-76.7%
Q3 FY2019Sep 30, 2019$2.55M-75.3%
Q2 FY2019Jun 30, 2019$4.50M-62.5%
Q1 FY2019Mar 31, 2019$6.95M+28267.5%
Q4 FY2018Dec 31, 2018$8.60M+5233.9%
Q3 FY2018Sep 30, 2018$10.31M+2657.0%
Q2 FY2018Jun 30, 2018$12.00M+2464.7%
Q1 FY2018Mar 31, 2018$24.49K-97.4%
Q4 FY2017Dec 31, 2017$161.25K-89.9%
Q3 FY2017Sep 30, 2017$373.95K-61.4%
Q2 FY2017Jun 30, 2017$467.94K–
Q1 FY2017Mar 31, 2017$930.01K–
Q4 FY2016Dec 31, 2016$1.60M–
Q3 FY2016Sep 30, 2016$968.58K–

More Genprex figures

See a number that looks wrong?